ICMR transfers three indigenous biomedical technologies to advance cancer and infectious disease solutions

ICMR transfers three indigenous biomedical technologies to advance cancer and infectious disease solutions: NEW DELHI, 21 JULY ( PIB).The Indian Council of Medical Research (ICMR), under its Medical Innovations Patent Mitra initiative, facilitated the licensing of three indigenous biomedical technologies to leading Indian pharmaceutical and vaccine manufacturers for further development, manufacturing and commercialization. The technologies include SHetA2, a novel anti-HPV therapeutic candidate for the treatment of Cervical